0000899243-18-007933.txt : 20180319 0000899243-18-007933.hdr.sgml : 20180319 20180319161059 ACCESSION NUMBER: 0000899243-18-007933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180315 FILED AS OF DATE: 20180319 DATE AS OF CHANGE: 20180319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lowery Thomas J. CENTRAL INDEX KEY: 0001615632 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 18698846 MAIL ADDRESS: STREET 1: T2 BIOSYSTEMS, INC. STREET 2: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-15 0 0001492674 T2 Biosystems, Inc. TTOO 0001615632 Lowery Thomas J. 101 HARTWELL AVENUES LEXINGTON MA 02421 0 1 0 0 Chief Scientific Officer Performance Restricted Stock Units 2018-03-15 4 A 0 107386 0.00 A 2021-03-15 Common Stock 107386 107386 D Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock upon the achievement of certain pre-established 90-day average daily closing prices per share goals over a three-year performance period. /s/ John Sprague, Attorney-in-Fact 2018-03-19